These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12532227)

  • 1. Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin.
    Khynriam D; Prasad SB
    Braz J Med Biol Res; 2003 Jan; 36(1):53-63. PubMed ID: 12532227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment.
    Nicol BM; Prasad SB
    Braz J Med Biol Res; 2002 May; 35(5):549-53. PubMed ID: 12011939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma.
    Khynriam D; Prasad SB
    Mutat Res; 2003 May; 526(1-2):9-18. PubMed ID: 12714178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in glutathione-related enzymes in tumor-bearing mice after cisplatin treatment.
    Khynriam D; Prasad SB
    Cell Biol Toxicol; 2002; 18(6):349-58. PubMed ID: 12484546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice.
    Martha KR; Rosangkima G; Amenla L; Rongpi T; Prasad SB
    Fundam Clin Pharmacol; 2013 Jun; 27(3):329-38. PubMed ID: 22211279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma.
    Rosangkima G; Prasad SB
    Indian J Exp Biol; 2004 Oct; 42(10):981-8. PubMed ID: 15511001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
    Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
    Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical changes associated with ascorbic acid-cisplatin combination therapeutic efficacy and protective effect on cisplatin-induced toxicity in tumor-bearing mice.
    Longchar A; Prasad SB
    Toxicol Rep; 2015; 2():489-503. PubMed ID: 28962385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice.
    Prasad SB; Rosangkima G; Kharbangar A
    Mitochondrion; 2010 Jan; 10(1):38-45. PubMed ID: 19766736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of the methanolic extract of Ammannia baccifera L. against Dalton's ascites lymphoma induced ascitic and solid tumors in mice.
    Loganayaki N; Manian S
    J Ethnopharmacol; 2012 Jun; 142(1):305-9. PubMed ID: 22613234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effect of Zingiber officinale Against Dalton's Lymphoma Ascites Tumour by Regulating Inflammatory Mediator and Cytokines.
    Rubila S; Ranganathan TV; Sakthivel KM
    Appl Biochem Biotechnol; 2016 Dec; 180(8):1482-1496. PubMed ID: 27435276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
    Prasad SB; Giri A; Arjun J
    Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of cisplatin against murine ascites Dalton's lymphoma.
    Prasad SB; Giri A
    Indian J Exp Biol; 1994 Mar; 32(3):155-62. PubMed ID: 8070834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of Dalton's lymphoma-induced angiogenesis by melatonin.
    Kumari R; Rawat K; Kumari A; Shrivastava A
    Tumour Biol; 2017 Jun; 39(6):1010428317705758. PubMed ID: 28618962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-cell association in ascites Dalton's lymphoma and the effect of cisplatin in vivo.
    Prasad SB; Arjun J
    Anticancer Drugs; 1991 Feb; 2(1):57-62. PubMed ID: 1958853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice.
    Khynriam D; Prasad SB
    Cell Biol Toxicol; 2001; 17(6):357-70. PubMed ID: 11787858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model.
    Sriram MI; Kanth SB; Kalishwaralal K; Gurunathan S
    Int J Nanomedicine; 2010 Oct; 5():753-62. PubMed ID: 21042421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorambucil and ascorbic acid-mediated anticancer activity and hematological toxicity in Dalton's ascites lymphoma-bearing mice.
    Kalita S; Verma AK; Prasad SB
    Indian J Exp Biol; 2014 Feb; 52(2):112-24. PubMed ID: 24597143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.